2,813
Views
18
CrossRef citations to date
0
Altmetric
Drug Profile

SQ house dust mite (HDM) SLIT-tablet provides clinical improvement in HDM-induced allergic rhinitis

, , , , &
Pages 369-377 | Received 13 Nov 2015, Accepted 18 Jan 2016, Published online: 11 Feb 2016

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Peter A. Ricketti, Sultan Alandijani, Chen Hsing Lin & Thomas B. Casale. (2017) Investigational new drugs for allergic rhinitis. Expert Opinion on Investigational Drugs 26:3, pages 279-292.
Read now
Pascal Demoly, Yoshitaka Okamoto, William H. Yang, Philippe Devillier & Karl-Christian Bergmann. (2016) 300 IR HDM tablet: a sublingual immunotherapy tablet for the treatment of house dust mite-associated allergic rhinitis. Expert Review of Clinical Immunology 12:11, pages 1141-1151.
Read now
Giorgio Walter Canonica, Johann Christian Virchow, Petra Zieglmayer, Christian Ljørring, Ida Mosbech Smith & Holger Mosbech. (2016) Efficacy and safety of SQ house dust mite (HDM) SLIT-tablet treatment of HDM allergic asthma. Expert Review of Clinical Immunology 12:8, pages 805-815.
Read now

Articles from other publishers (15)

Marguerite Thétis-Soulié, Maxime Hosotte, Isabelle Grozelier, Claire Baillez, Silvia Scurati & Valérie Mercier. (2022) The MaDo real-life study of dose adjustment of allergen immunotherapy liquid formulations in an indication of respiratory allergic disease: Reasons, practices, and outcomes. Frontiers in Allergy 3.
Crossref
Tilo Biedermann, Peter Couroux, Tina Maria Greve & Mika Mäkelä. (2021) Safety of the standardized quality tree sublingual immunotherapy tablet: Pooled safety analysis of clinical trials. Allergy 76:12, pages 3733-3742.
Crossref
Rainer Reiber, Hendrik Wolf, Thomas Futschik, Jan-Alexander Schwab, Uwe Hölscher, Jörg Schnitker & Eike Wüstenberg. (2021) Safety and tolerability of the standardized quality house dust mite sublingual immunotherapy tablet in real life: A noninterventional, open-label study. The Journal of Allergy and Clinical Immunology: In Practice 9:8, pages 3221-3223.e5.
Crossref
Irina Bucur & Florica Popescu. (2020) Pharmaceutical presentation of tablets for sublingual allergen immunotherapy available worldwide. Alergologia 2:4, pages 87.
Crossref
Elizabeth Mason & Efren Rael. 2019. Allergy and Asthma. Allergy and Asthma 943 960 .
Jie Yang, Li Zhang, Zhixiang Zhao & Shiyu Liao. (2018) Sublingual immunotherapy for pediatric allergic conjunctivitis: a meta-analysis of randomized controlled trials. International Forum of Allergy & Rhinology 8:11, pages 1253-1259.
Crossref
Joshua M. Levy & Sarah K. Wise. 2018. Evidence-Based Clinical Practice in Otolaryngology. Evidence-Based Clinical Practice in Otolaryngology 73 81 .
Martin A. Smith & David M. Lang. 2018. Rhinitis and Related Upper Respiratory Conditions. Rhinitis and Related Upper Respiratory Conditions 9 16 .
Elizabeth Mason & Efren Rael. 2019. Allergy and Asthma. Allergy and Asthma 1 18 .
Cevdet Ozdemir, M?beccel Akdis & Cezmi A. Akdis. (2017) Precision Medicine in Allergic Disorders. Current Treatment Options in Allergy 4:2, pages 283-285.
Crossref
Åse Björstad, Lars-Olaf Cardell, Julie Hahn-Pedersen & Mikael Svärd. (2017) A Cost-Minimisation Analysis Comparing Sublingual Immunotherapy to Subcutaneous Immunotherapy for the Treatment of House Dust Mite Allergy in a Swedish Setting. Clinical Drug Investigation 37:6, pages 541-549.
Crossref
Galateja Jordakieva, Michael Kundi, Patrick Lemell, René Zieglmayer, Petra Zieglmayer, Jasminka Godnic-Cvar & Erika Jensen-Jarolim. (2017) Sublingual house dust mite immunotherapy has no impact on decrease of circulating erythrocytes upon airway allergen challenge in allergic rhinitis. Scientific Reports 7:1.
Crossref
Robert K. Bush. (2017) Dust Mite Tablet Immunotherapy: How Does It Compare and Where Does It Fit?. Current Treatment Options in Allergy 4:1, pages 14-21.
Crossref
Yasuhiro Gon, Shuichiro Maruoka, Reiko Ito & Shu Hashimoto. (2017) Immunotherapy in Lung Disease. Journal of Nihon University Medical Association 76:1, pages 36-39.
Crossref
Bohai FengHaijie XiangHaiyong JinJinjian GaoSaiyu HuangYunbin ShiRuru ChenBobei Chen. (2017) Efficacy of Sublingual Immunotherapy for House Dust Mite-Induced Allergic Rhinitis: A Meta-Analysis of Randomized Controlled Trials. Allergy, Asthma & Immunology Research 9:3, pages 220.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.